Related Experiment Video
Updated: May 6, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Idasanutlin-ionizable lipid nanocomplex for enhanced solubility, stability, and anticancer activity in p53 sensitive
Bhoomi Dholariya1, Akanksha Patel1, Rhema Khairnar1
1College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11432, USA.
Abstract:
Lung cancer is a leading cause of cancer-related mortality worldwide due to increasing incidence and poor clinical outcomes. Over 50 % of human cancers involve alterations in the tumor suppressor protein p53, mostly resulting in loss of function. Idasanutlin (IDA), a hydrophobic, anionic molecule, is a potent MDM2 inhibitor capable of restoring p53 activity in cancers retaining wild-type (WT) p53. This study aimed to develop an IDA loaded lipid Nanocomplex (IDLIN) for enhancing solubility, stability and loading efficiency followed by systematically testing its effectiveness in non-small cell lung cancer (NSCLC). We hypothesized that incorporating a hydrophobic ion-pairing agent would enhance IDA encapsulation by forming a lipophilic complex. A self-nanoemulsifying drug delivery system (SNEDDS) was formulated using a hydrophobic nanocomplex of IDA and a cationic ionizable lipid, DLin-DMA, resulting in significantly improved physical stability and loading efficiency. IDLIN exhibited a mean droplet size of 81.17 ± 0.485 nm, polydispersity index of 0.122 ± 0.009, and zeta potential of -3.18 ± 0.956 mV at physiological pH and + 11.37 ± 0.404 mV at tumor microenvironment mimicking pH. IDLIN demonstrated potent anticancer activity in NSCLC cell lines A549, H460, and PC9. IDLIN resisted drug precipitation, inhibited colony formation, and was well tolerated for intravenous administration, showing negligible hemolysis. Western blot analysis revealed upregulation of p53 and MDM2 proteins in IDLIN-treated cells. In 3D tumor spheroid models, IDLIN significantly inhibited tumor growth compared to control. This study presents IDLIN as a promising nanoformulation for delivery of IDA, demonstrating therapeutic potential in NSCLC treatment.
Insights
This study developed a novel Idasanutlin loaded lipid Nanocomplex (IDLIN) to improve treatment for non-small cell lung cancer (NSCLC). IDLIN effectively delivered Idasanutlin, restoring p53 activity and showing significant anti-cancer effects in NSCLC models.
Area of Science:
- Nanotechnology
- Oncology
- Drug Delivery
Background:
- Lung cancer remains a leading cause of cancer mortality globally, often linked to p53 tumor suppressor gene dysfunction.
- Idasanutlin (IDA) is an MDM2 inhibitor that can restore p53 activity in wild-type p53 cancers, but its clinical application is limited by poor solubility and stability.
Purpose of the Study:
- To develop a novel Idasanutlin-loaded lipid Nanocomplex (IDLIN) to enhance solubility, stability, and loading efficiency of IDA.
- To evaluate the therapeutic potential of IDLIN in non-small cell lung cancer (NSCLC) models.
Main Methods:
- Formulation of IDLIN using a self-nanoemulsifying drug delivery system (SNEDDS) with a hydrophobic ion-pairing agent (DLin-DMA).
- Characterization of IDLIN's physical properties (size, PDI, zeta potential) at different pH values.
- In vitro evaluation of IDLIN's anti-cancer activity in NSCLC cell lines (A549, H460, PC9) and 3D tumor spheroid models.
- Assessment of IDLIN's in vivo tolerability (hemolysis) and mechanism of action (Western blot analysis for p53 and MDM2).
Main Results:
- IDLIN demonstrated significantly improved physical stability and loading efficiency compared to IDA alone.
- IDLIN exhibited potent anti-cancer activity in NSCLC cell lines, inhibiting colony formation and tumor growth in 3D models.
- Western blot analysis confirmed p53 and MDM2 upregulation in IDLIN-treated cells, indicating restored p53 pathway activity.
- IDLIN showed good tolerability for intravenous administration with negligible hemolysis.
Conclusions:
- IDLIN represents a promising nanoformulation for Idasanutlin delivery, enhancing its therapeutic potential in NSCLC.
- The developed nano-delivery system effectively overcomes IDA's limitations, offering a viable strategy for NSCLC treatment.
Related Concept Videos
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Abnormal Proliferation

